James Onder, one of the lead attorneys on the recent talc case which resulted in a $72 million plaintiffs verdict, will be speaking at the March 11th – 14th Four Days to Mass Tort Success Course. If you are considering getting involved in the Talc Ovarian Cancer Litigation, getting to know James would be a smart move.
Taxotere Emerging Litigation
Darin Shanker of Bachus and Shanker will be discussing the emerging Taxotere litigation at the March 11th-14th course as well. The attorneys are leading the Taxotere emerging litigation. You do not want to miss out on an opportunity to get information from the most authoritative source on this litigation.
If you are not already registered for the Next Four Days to Mass Tort Success course, being held at the W Hotel in Fort Lauderdale Beach March 11-14, contact Barbara Capasso today. The course is full, however, Barbara will add a couple of additional seats for those interested in the talc and Taxotere litigations.
Contact Barbara: (954) 383-3932 or email her at email@example.com to register for the March Course.
Essure Litigation Update
On February 29, 2016 the United States Food and Drug Administration took certain actions related to the Essure Permanent Birth Control Device. John Ray has published a new paper intended to address certain questions related to if and how the actions of the FDA will impact certain aspects of the ongoing Essure Litigation specifically related to the defendants Prior Market Approval (PMA) preemption arguments.